Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ciliary microtubule inner protein 5 (CIMIP5, C2orf50) is putatively assigned as a member of the microtubule inner proteins (MIPs) that localize to the inner lumen of axonemal doublet microtubules in cilia[1][4]. The protein is only referenced in large-scale proteomic or structural studies aiming to catalog components within ciliary microtubule architectures[1]. Its precise molecular function, biological role, or disease associations have not been substantiated; no enzymatic activity or receptor function is attributed, and no pharmacological targets or interactions are reported[1][4]. Standard protein databases and recent reviews do not list functional data, clear disease link, nor experimental manipulation for CIMIP5/C2orf50. This makes it an "uncharacterized" or "putative" ciliary protein rather than a validated therapeutic or biomarker target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ciliary microtubule inner protein 5 (CIMIP5).